about
Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fateCorrelation between virus persistent infection and cardic function in patients with dilated cardiomyopathyAcute histologic chorioamnionitis at term: nearly always noninfectiousNasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditisA DPP-4 inhibitor suppresses fibrosis and inflammation on experimental autoimmune myocarditis in mice.Toll-like receptors and myocardial inflammation.Silencing of CCR2 in myocarditis.Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fiction.Eosinophils in patients with lone atrial fibrillation.Cacao polyphenols ameliorate autoimmune myocarditis in mice.Correlations among persistent viral infection, heart function and Chinese medicine syndromes in dilated cardiomyopathy patients.Association between serum immunoglobulin G4 concentration and cardiac function among elderly cardiology inpatients.Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis.Immune checkpoint inhibitor-related myocarditis.Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.Mortality and morbidity in different immunization protocols for experimental autoimmune myocarditis in rats.Inhibition of NF-κB activation by a novel IKK inhibitor reduces the severity of experimental autoimmune myocarditis via suppression of T-cell activation.Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis
P2860
Q30425184-4DB41765-4EE9-496B-8447-4E1B90A3CE98Q34037669-6EF3BD21-BC0A-433B-AF2E-C0ECEEB69A00Q34192996-FB0131F6-411F-47E9-BAA6-4B3F02CCFDB3Q34819379-FCE80CB6-1F9C-4366-97D3-014EDEEDEAB8Q35175774-52AD7DE2-523E-4CCF-8BEB-556845D57800Q35240118-7F62E223-3492-4C89-AC11-8D7C0EEFA28AQ35737489-FE5EACEF-5637-43C0-9269-E3F498C48E10Q36990126-B233CD4C-3CAA-42E3-9FAA-B3510778C940Q37852758-58BE904C-8433-4790-9126-E35DD48D4973Q38112727-31D19297-2762-44FC-9512-70E5F4E4D937Q38714286-2623DDDE-A0EF-4AFB-A36A-6122888B3578Q40222022-8D5DBF51-47E0-4A06-9ABB-2D295A6FBD58Q42206364-ED703748-3645-49DE-8B75-A6DCF92E65B9Q43889763-E2043BAE-B8B3-4001-B2A7-AF1391EF28C8Q45718660-50D8604A-77F1-410E-BED6-B28995F326AAQ47633085-19C49FD1-C583-426B-9D44-30709140798AQ52717837-25AFEEB5-98DD-4481-BABE-8BB47D8C5076Q52880343-C6E3258E-DB17-49DB-A509-B06B8B7BB709Q54405098-F8506927-3986-4818-B719-C4367F113BBBQ55166882-3459C856-9E84-486F-BC15-96E68CD1F0C8Q57817469-A10A11E3-2720-4E7C-86AD-39B6EDCEC14E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmune myocarditis: past, present and future.
@en
Autoimmune myocarditis: past, present and future.
@nl
type
label
Autoimmune myocarditis: past, present and future.
@en
Autoimmune myocarditis: past, present and future.
@nl
prefLabel
Autoimmune myocarditis: past, present and future.
@en
Autoimmune myocarditis: past, present and future.
@nl
P2093
P1476
Autoimmune myocarditis: past, present and future.
@en
P2093
Florian Leuschner
Hugo A Katus
P304
P356
10.1016/J.JAUT.2009.07.009
P577
2009-08-12T00:00:00Z